The first domestic fluticasone propionate inhalation powder spray has been approved for market launch.

According to the news from Chongqing Liangjiang New Area, the "Fluticasone Furoate Inhalation Powder Aerosol" developed by the Liangjiang New Area enterprise Runsheng Pharmaceutical has successfully obtained market approval. This marks a major technological breakthrough for Runsheng Pharmaceutical in the high-end inhalation powder aerosol field, becoming the first domestic product in this field, providing asthma patients with more efficient, convenient, and safer treatment options.